These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3352859)

  • 1. Plasma oxalate in chronic renal failure and normal subjects: methodological problems.
    Dorhout Mees EJ; Boer P
    Nephron; 1988; 48(3):256-7. PubMed ID: 3352859
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S; Hatch M
    Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hyperoxalemia in chronic renal failure.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary oxalosis in chronic renal insufficiency].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of plasma oxalate with soluble oxalate oxidase.
    Petrarulo M; Cerelli E; Marangella M; Cosseddu D; Vitale C; Linari F
    Clin Chem; 1994 Nov; 40(11 Pt 1):2030-4. PubMed ID: 7955374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxalic acid metabolism in chronic renal failure].
    Balcke P
    Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion chromatographic determination of plasma oxalate in healthy subjects, in patients with chronic renal failure and in cases of hyperoxaluric syndromes.
    Petrarulo M; Bianco O; Marangella M; Pellegrino S; Linari F; Mentasti E
    J Chromatogr; 1990 Jul; 511():223-31. PubMed ID: 2211912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure.
    France NC; Holland PT; Wallace MR
    Clin Chem; 1994 Aug; 40(8):1544-8. PubMed ID: 8044994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A
    Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
    [No Abstract]   [Full Text] [Related]  

  • 14. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells.
    Levin RI; Kantoff PW; Jaffe EA
    Arteriosclerosis; 1990; 10(2):198-207. PubMed ID: 2317157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
    Mydlík M; Derzsiová K; Pribylincová V; Reznícek J
    Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of oxalic acid in plasma and urine by means of capillary gas chromatography.
    Wolthers BG; Hayer M
    Clin Chim Acta; 1982 Mar; 120(1):87-102. PubMed ID: 7067141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors contributing to oxalate deposits in the myocardia of hemodialysis patients.
    Ono K; Kikawa K
    ASAIO Trans; 1989; 35(3):595-7. PubMed ID: 2597543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate crystal deposits in renal tubules and cystic changes in 5/6 nephrectomized and normal rats.
    Ono K; Kikawa K
    ASAIO Trans; 1989; 35(3):629-31. PubMed ID: 2597553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxalate retention in chronic renal failure: tubular vs glomerular diseases.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Clin Nephrol; 1989 Aug; 32(2):87-95. PubMed ID: 2788548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.